All News
Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.
Read MoreEmbattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead
(MedPage Today) -- For a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform, the much-litigated Myval performed well enough in the COMPARE-TAVI 1 randomized trial, but
Read MoreSwitch to Tirzepatide in T2D More Effective Than Upping Dulaglutide Dose
(MedPage Today) -- Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide (Mounjaro) rather than increasing the dose of the earl
Read MoreSTAT+: Trump administration declines to expand Medicare coverage for obesity drugs
The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed Medicare to cover blockbuster weight loss drugs.
Read MoreNIOSH Workers Wonder, 'Who Is Going to Carry on My Work?'
(MedPage Today) -- This week's cuts to HHS staffing have left employees at one agency division wondering what will become of all of their research.
Read MoreMedicare Spends Billions on Oncology Drugs Offering Little Added Benefit
(MedPage Today) -- In an analysis of Medicare's top-selling brand-name oncology drugs, researchers found that while the vast majority provided high added therapeutic benefit, 10 were classified as pr
Read MoreU.S. Has Twice as Many Measles Cases so Far This Year Than in All of 2024
(MedPage Today) -- The U.S. now has more than double the number of measles cases it saw in all of 2024, with Texas reporting another large jump in cases and hospitalizations on Friday.
Read MoreCerebrospinal Fluid Liquid Biopsy for Glioma Shows Clinical Management Potential
(MedPage Today) -- Circulating tumor DNA (ctDNA) in cerebrospinal fluid (CSF) of patients with glioma had a high concordance with tumor DNA and showed potentially useful prognostic potential, a small
Read MoreSTAT+: FDA tells drugmakers to redo studies run by a contract research firm due to data integrity issues
Citing "objectionable conditions," the agency said there were problems with the way Raptim Research tested medicines in India.
Read MoreAmid Measles Outbreaks, Poison Centers See Uptick in Vit A Exposures in Kids
(MedPage Today) -- Poison control centers have received more reports of vitamin A exposures than usual -- a trend that lines up with the growing measles outbreaks in Texas and other states.
Read More